Chapter/Section Purchase

1 Peripheral Intervention Drug-Eluting Devices Market Overview
1.1 Product Overview and Scope of Peripheral Intervention Drug-Eluting Devices
1.2 Peripheral Intervention Drug-Eluting Devices Segment by Type
1.2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Growth Rate Comparison by Type (2023-2029)
1.2.2 Drug-Eluting Balloons
1.2.3 Drug-Eluting Stents
1.3 Peripheral Intervention Drug-Eluting Devices Segment by Application
1.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Comparison by Application: (2023-2029)
1.3.2 Plain Old Balloon Angioplasty (POBA)
1.3.3 Percutaneous Transluminal Angioplasty (PTA)
1.4 Global Peripheral Intervention Drug-Eluting Devices Market Size Estimates and Forecasts
1.4.1 Global Peripheral Intervention Drug-Eluting Devices Revenue 2018-2029
1.4.2 Global Peripheral Intervention Drug-Eluting Devices Sales 2018-2029
1.4.3 Peripheral Intervention Drug-Eluting Devices Market Size by Region: 2018 Versus 2022 Versus 2029
2 Peripheral Intervention Drug-Eluting Devices Market Competition by Manufacturers
2.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Peripheral Intervention Drug-Eluting Devices Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Peripheral Intervention Drug-Eluting Devices Manufacturing Sites, Area Served, Product Type
2.5 Peripheral Intervention Drug-Eluting Devices Market Competitive Situation and Trends
2.5.1 Peripheral Intervention Drug-Eluting Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Peripheral Intervention Drug-Eluting Devices Players Market Share by Revenue
2.5.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario by Region
3.1 Global Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Peripheral Intervention Drug-Eluting Devices Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.3.1 North America Peripheral Intervention Drug-Eluting Devices Sales by Country
3.3.2 North America Peripheral Intervention Drug-Eluting Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.4.1 Europe Peripheral Intervention Drug-Eluting Devices Sales by Country
3.4.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales by Region
3.5.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.6.1 Latin America Peripheral Intervention Drug-Eluting Devices Sales by Country
3.6.2 Latin America Peripheral Intervention Drug-Eluting Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Country
3.7.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Peripheral Intervention Drug-Eluting Devices Historic Market Analysis by Type
4.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Type (2018-2023)
4.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2018-2023)
4.3 Global Peripheral Intervention Drug-Eluting Devices Price by Type (2018-2023)
5 Global Peripheral Intervention Drug-Eluting Devices Historic Market Analysis by Application
5.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2018-2023)
5.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Application (2018-2023)
5.3 Global Peripheral Intervention Drug-Eluting Devices Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Medtronic plc
6.1.1 Medtronic plc Corporation Information
6.1.2 Medtronic plc Description and Business Overview
6.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.1.5 Medtronic plc Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Cardinal Health
6.4.1 Cardinal Health Corporation Information
6.4.2 Cardinal Health Description and Business Overview
6.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.4.5 Cardinal Health Recent Developments/Updates
6.5 B. Braun Melsungen AG
6.5.1 B. Braun Melsungen AG Corporation Information
6.5.2 B. Braun Melsungen AG Description and Business Overview
6.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.5.5 B. Braun Melsungen AG Recent Developments/Updates
6.6 Biosensors International Group Ltd.
6.6.1 Biosensors International Group Ltd. Corporation Information
6.6.2 Biosensors International Group Ltd. Description and Business Overview
6.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.6.5 Biosensors International Group Ltd. Recent Developments/Updates
6.7 C.R. Bard, Inc.
6.6.1 C.R. Bard, Inc. Corporation Information
6.6.2 C.R. Bard, Inc. Description and Business Overview
6.6.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.7.5 C.R. Bard, Inc. Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Corporation Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Abbott Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 The Lubrizol Corporation
6.9.1 The Lubrizol Corporation Corporation Information
6.9.2 The Lubrizol Corporation Description and Business Overview
6.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.9.4 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.9.5 The Lubrizol Corporation Recent Developments/Updates
6.10 Terumo Corporation
6.10.1 Terumo Corporation Corporation Information
6.10.2 Terumo Corporation Description and Business Overview
6.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Portfolio
6.10.5 Terumo Corporation Recent Developments/Updates
7 Peripheral Intervention Drug-Eluting Devices Manufacturing Cost Analysis
7.1 Peripheral Intervention Drug-Eluting Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Peripheral Intervention Drug-Eluting Devices
7.4 Peripheral Intervention Drug-Eluting Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Peripheral Intervention Drug-Eluting Devices Distributors List
8.3 Peripheral Intervention Drug-Eluting Devices Customers
9 Peripheral Intervention Drug-Eluting Devices Market Dynamics
9.1 Peripheral Intervention Drug-Eluting Devices Industry Trends
9.2 Peripheral Intervention Drug-Eluting Devices Market Drivers
9.3 Peripheral Intervention Drug-Eluting Devices Market Challenges
9.4 Peripheral Intervention Drug-Eluting Devices Market Restraints
10 Global Market Forecast
10.1 Peripheral Intervention Drug-Eluting Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Peripheral Intervention Drug-Eluting Devices by Type (2023-2029)
10.1.2 Global Forecasted Revenue of Peripheral Intervention Drug-Eluting Devices by Type (2023-2029)
10.2 Peripheral Intervention Drug-Eluting Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Peripheral Intervention Drug-Eluting Devices by Application (2023-2029)
10.2.2 Global Forecasted Revenue of Peripheral Intervention Drug-Eluting Devices by Application (2023-2029)
10.3 Peripheral Intervention Drug-Eluting Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Peripheral Intervention Drug-Eluting Devices by Region (2023-2029)
10.3.2 Global Forecasted Revenue of Peripheral Intervention Drug-Eluting Devices by Region (2023-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer